Medical Condition News

RSS

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Tinnitus, migraine, epilepsy, depression, schizophrenia, Alzheimer's: all these are examples of diseases with neurological causes, the treatment and study of which is more and more frequently being carried out by means of magnetic stimulation of the brain. However, the method's precise mechanisms of action have not, as yet, been fully understood.

5 Sep 2014

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

5 Sep 2014

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2

4 Sep 2014

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer.

4 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration, South Korea’s Ministry of Food and Drug Safety, and the Taiwan Food and Drug Administration for the company’s REVIVE SE Thrombectomy Device, a next-generation self-expanding clot removal device intended to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

4 Sep 2014

Using handheld Raman scanner researchers completely removed brain tumors

Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them - and for leading to a dire prognosis for patients.

4 Sep 2014

Study investigates white matter damage in chronic stages of traumatic axonal injury

Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.

4 Sep 2014

Researchers examine which condition comes first - childhood obesity or asthma?

For years, doctors have known that there is a link between childhood obesity and asthma, but have found it difficult to determine which condition tends to come first, or whether one causes the other.

4 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

Study investigates whether function of intestines attacked in MS

The present study investigates whether the function of the intestines is also attacked in MS. The results, obtained from a disease model of MS in mice, shows inflammation and changes in the barrier function of the intestines early in the course of the disease.

4 Sep 2014

Scientists aim to develop rapid test system for immune dysfunction to treat cystic fibrosis

Cystic fibrosis (CF) is a frequent genetic disease affecting the lung and the gastrointestinal tract. Scientists from the Helmholtz Zentrum München now have shown that many of the adult patients with CF in addition lack a cell surface molecule, which is important for immune defence. The results have been published recently in the 'Journal of Molecular Medicine'.

4 Sep 2014

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

4 Sep 2014

Research to identify cancer-busting 'genetic partners' can personalize cancer treatment

Despite the revolutionary biotechnological advancements of the last few decades, an ideal anti-cancer treatment - one that's immediately lethal to cancer cells, harmless to healthy cells, and resistant to cancer's relapse - is still a dream.

4 Sep 2014

Two week stay in specialized hospital may help manage insomnia

Insomnia is a disturbance that afflicts many people. Some new findings published in the current issue of Psychotherapy and Psychosomatics indicate that a two week stay in a specialized hospital may help.

4 Sep 2014

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world.

4 Sep 2014

Investigators report on potential effects of hormone in borderline personality disorder

In the current issue of Psychotherapy and Psychosomatics a group of German investigators is reporting on the potential effects of a hormone in borderline personality disorder.

4 Sep 2014

Study shows 1 in 10 patients may not need surgery following heart attack

Researchers from the Golden Jubilee National Hospital and the University of Glasgow have reported a study that shows one in ten patients may not need cardiac intervention following a heart attack and in those that do need stents, the procedure can be targeted more effectively.

4 Sep 2014

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Chronic tinnitus is a disabling disorder. A new study published in the current issue of Psychotherapy and Psychosomatics reports on a therapy that is performed over internet.

4 Sep 2014

Researchers uncover intriguing link between heart attacks and protein

A team of researchers at the University of Ottawa Heart Institute, led by Dr. Alexandre Stewart, have uncovered an intriguing link between heart attacks and a protein that is of great interest to drug companies for its impact on cholesterol.

4 Sep 2014

Medical Condition News

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Keytruda drug gets FDA approval for treatment of advanced melanoma

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Using handheld Raman scanner researchers completely removed brain tumors

Study investigates white matter damage in chronic stages of traumatic axonal injury

Researchers examine which condition comes first - childhood obesity or asthma?

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Study investigates whether function of intestines attacked in MS

Scientists aim to develop rapid test system for immune dysfunction to treat cystic fibrosis

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Research to identify cancer-busting 'genetic partners' can personalize cancer treatment

Two week stay in specialized hospital may help manage insomnia

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Investigators report on potential effects of hormone in borderline personality disorder

Study shows 1 in 10 patients may not need surgery following heart attack

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Researchers uncover intriguing link between heart attacks and protein

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News